Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetomilast in active Crohn's disease
NCT00989573Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Oct 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tetomilast in Crohn's disease, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Oct 2009; status: completed.
02
Drugs
tetomilast
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00989573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989573.